Keywords: Merck & Co, Subpoena, Department of Justice, Marketing practices, USA

Merck & Co gets subpoena over cancer and antiviral drug marketing in USA

Article | 09 August 2011

Print This

Merck & Co (NYSE: MRK) has received a subpoena from the US Department of Justice as part of a criminal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in